THE EXPRESSION OF DYSTROPHIN-ASSOCIATED GLYCOPROTEINS DURING SKELETAL-MUSCLE DEGENERATION AND REGENERATION - AN IMMUNOFLUORESCENCE STUDY

被引:24
作者
VATER, R
HARRIS, JB
ANDERSON, LVB
ROBERDS, SL
CAMPBELL, KP
CULLEN, MJ
机构
[1] UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,IOWA CITY,IA
[2] UNIV IOWA,COLL MED,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA
关键词
ADHALIN; ALPHA-DYSTROGLYCAN; BETA-DYSTROGLYCAN; DYSTROPHIN; MUSCLE DEGENERATION; MUSCLE REGENERATION; PLASMA MEMBRANE;
D O I
10.1097/00005072-199507000-00010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The distribution and expression of dystrophin and three of the dystrophin-associated glycoproteins (DAG), alpha-dystroglycan (156 kDa DAG), beta-dystroglycan (43 kDa DAG) and adhalin (50 kDa DAG) in rat skeletal muscle were studied during a controlled cycle of degeneration and regeneration induced by the injection of a snake venom. Cryosections of muscle at various stages of degeneration and regeneration were labeled using monoclonal antibodies to the three glycoproteins and examined at fixed time points after venom injection. Adhalin and alpha-dystroglycan remained present at the sarcolemma throughout the entire cycle of degeneration and regeneration. beta-Dystroglycan, on the other hand, was lost from the sarcolemma by 12 hours and reappeared 2 days after venom injection when new muscle fibers were being formed. Dystrophin was not lost from the sarcolemma until 24 hours after venom injection and did not reappear at the membrane until 4 days. It is suggested that dystrophin and the glycoprotein complex are synthesized separately, both temporally and spatially, and only become associated at the plasma membrane during the later stages of regeneration. The expression of beta-dystroglycan in the regenerating muscle fibers was first seen at sites of newly forming plasma membrane that were closely associated with the old basal lamina tube. The basal lamina may therefore have a regulatory or modulatory role in the expression of the DAG.
引用
收藏
页码:557 / 569
页数:13
相关论文
共 40 条
[1]  
Emery A., Duchenne Muscular Dystrophy, (1993)
[2]  
Hoffman E.P., Brown R.H., Kunkel L.M., Dystrophin: The protein product of the Duchenne muscular dystrophy locus, Cell, 51, pp. 919-928, (1987)
[3]  
Koenig M., Hoffman E.P., Bcrtclson C.J., Monaco A.P., Feener C., Kun-Kel L.M., Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organisation of the DMD gene in normal and affected individuals, Cell, 50, pp. 509-517, (1987)
[4]  
Arahata K., Ishiura S., Ishiguro T., Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide, Nature, 333, pp. 861-863, (1988)
[5]  
Bonilla E., Samitt C.E., Miranda A.F., Duchenne muscular dystrophy: Deficiency of dystrophin at the muscle cell surface, Cell, 54, pp. 447-452, (1988)
[6]  
Sugita H., Arahata K., Ishiguro T., Negative immunostaining of Duchenne muscular dystrophy (DMD) and mdx muscle surface membrane with antibody against synthetic peptide fragment predicted from DMD cDNA, Proc Jpn Acad, 64, pp. 37-39, (1988)
[7]  
Zubrzycka-Gaam E.E., Bulman D.E., Karpati G., The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle, Nature, 333, pp. 466-469, (1988)
[8]  
Vater R., Cullen M.J., Nicholson L., Harris J.B., The fate of dystrophin during the degeneration and regeneration of the soleus muscle of the rat, Acta Neuropathol, 83, pp. 140-148, (1992)
[9]  
Pons F., Augier N., Leger J., Mornet D., Leger J.J., Isolated dystrophin molecules as seen by electron microscopy, Proc Natl Acad Sci USA, 87, pp. 7851-7855, (1990)
[10]  
Sato O., Nonomura Y., Kimura S., Maruyama K., Molecular shape of dystrophin, J Biochem, 112, pp. 631-636, (1992)